Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-25-018967
Filing Date
2025-05-14
Accepted
2025-05-14 16:41:27
Documents
61
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ef20047567_10q.htm   iXBRL 10-Q 994055
2 EXHIBIT 31.1 ef20047567_ex31-1.htm EX-31.1 14768
3 EXHIBIT 31.2 ef20047567_ex31-2.htm EX-31.2 14419
4 EXHIBIT 32.1 ef20047567_ex32-1.htm EX-32.1 5998
5 EXHIBIT 32.2 ef20047567_ex32-2.htm EX-32.2 6065
11 image01.jpg GRAPHIC 676484
  Complete submission text file 0001140361-25-018967.txt   6700911

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20250331.xsd EX-101.SCH 35086
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20250331_cal.xml EX-101.CAL 40356
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20250331_def.xml EX-101.DEF 156193
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20250331_lab.xml EX-101.LAB 530112
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20250331_pre.xml EX-101.PRE 293746
64 EXTRACTED XBRL INSTANCE DOCUMENT ef20047567_10q_htm.xml XML 654675
Mailing Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540
Business Address 303A COLLEGE ROAD EAST PRINCETON NJ 08540 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

EIN.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 25946542
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)